Mannatech, Incorporated

MTEX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009 FY2008 FY2007
Operating Activities
Net Income $-17.4M $-12.6M $6.6M
Depreciation & Amortization $12.3M $12.3M $10.2M
Depreciation — — —
Amortization — — —
Stock-Based Compensation $636.0K $727.0K $948.0K
Net Cash from Operating Activities $-10.3M $-19.9M $17.8M
Investing Activities
Capital Expenditures $2.8M $5.6M $13.4M
Business Acquisitions — — —
Net Cash from Investing Activities — — —
Financing Activities
Dividends Paid $1.1M $5.8M $9.5M
Stock Repurchases $0 — —
Net Cash from Financing Activities — — —
Net Change in Cash $-13.6M $-16.2M $1.4M
Free Cash Flow $-13.1M $-25.5M $4.4M
← Newer Page 3 of 3 Older →